Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells in Children and Young Adults With Recurrent, Progressive, or Refractory Brain Tumors

NCT04254419 is registered in ClinicalTrials.gov with Nationwide Children's Hospital as lead sponsor.

NCT NCT04254419
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04254419 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells in Children and Young Adults With Recurrent, Progressive, or Refractory Brain Tumors
Lead sponsor
Nationwide Children's Hospital
Phase
Phase 1
Overall status
Recruiting
Start date
March 4, 2025
Completion date
October 31, 2031
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high grade glioma